Patents by Inventor Elbert E. Harris

Elbert E. Harris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted caprolactam derivatives as antihypertensives
    Patent number: 4680392
    Abstract: The invention in its broad aspects relates to caprolactam derivatives which are useful as angiotensin converting enxyme inhibitors and as antihypertensives.
    Type: Grant
    Filed: May 19, 1986
    Date of Patent: July 14, 1987
    Assignee: Merck & Co., Inc.
    Inventors: Elbert E. Harris, Arthur A. Patchett, Eugene D. Thorsett
  • Bicyclic lactams as antihypertensives
    Patent number: 4661479
    Abstract: This invention relates to bicyclic lactams and derivatives thereof which are useful as converting enzyme inhibitors and as antihypertensives.
    Type: Grant
    Filed: July 15, 1983
    Date of Patent: April 28, 1987
    Assignee: Merck and Co., Inc.
    Inventors: Matthew J. Wyvratt, Jr., Eugene D. Thorsett, Edward W. Tristram, Arthur A. Patchett, Elbert E. Harris
  • Substituted caprolactam derivatives as antihypertensives
    Patent number: 4629787
    Abstract: The invention in its broad aspects relates to caprolactam derivatives which are useful as angiotensin converting enxyme inhibitors and as antihypertensives.
    Type: Grant
    Filed: July 2, 1982
    Date of Patent: December 16, 1986
    Assignee: Merck & Co., Inc.
    Inventors: Elbert E. Harris, Arthur A. Patchett, Eugene D. Thorsett
  • Substituted caprylolactam derivatives as anti-hypertensives
    Patent number: 4587238
    Abstract: The invention in its broad aspects relates to caprylolactam derivatives which are useful as angiotensin converting enzyme inhibitors and as antihypertensives.
    Type: Grant
    Filed: July 9, 1982
    Date of Patent: May 6, 1986
    Assignee: Merck & Co., Inc.
    Inventors: Elbert E. Harris, Arthur A. Patchett, Eugene D. Thorsett
  • Substituted enantholactam derivatives as antihypertensives
    Patent number: 4587050
    Abstract: The invention in its broad aspects relates to enantholactam derivatives which are useful as angiotensin converting enzyme inhibitors and antihypertensives.
    Type: Grant
    Filed: February 11, 1985
    Date of Patent: May 6, 1986
    Assignee: Merck & Co., Inc.
    Inventors: Elbert E. Harris, Eugene D. Thorsett, Arthur A. Patchett
  • Substituted caprolactam derivatives as antihypertensives
    Patent number: 4520021
    Abstract: Substituted caprolactam derivatives are disclosed which are useful as converting enzyme inhibitors and as antihypertensives.
    Type: Grant
    Filed: June 16, 1983
    Date of Patent: May 28, 1985
    Assignee: Merck & Co., Inc.
    Inventors: Elbert E. Harris, Eugene D. Thorsett
  • Amino acid derivatives as antihypertensives
    Patent number: 4472380
    Abstract: There are disclosed processes for preparing carboxyalkyl dipeptide derivatives and related compounds which are useful as angiotension converting enzyme (ACE) inhibitors and as antihypertensives and pharmaceutical compositions containing these carboxyalkyl dipeptide compounds in combination with another antihypertensive and/or diuretic compound.
    Type: Grant
    Filed: September 27, 1982
    Date of Patent: September 18, 1984
    Assignee: Merck & Co., Inc.
    Inventors: Elbert E. Harris, Arthur A. Patchett, Edward W. Tristram, Matthew J. Wyvratt
  • Bicyclic lactams
    Patent number: 4415496
    Abstract: The invention relates to bicyclic lactams and related compounds which are useful as antihypertensives.
    Type: Grant
    Filed: February 19, 1982
    Date of Patent: November 15, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Elbert E. Harris, Arthur A. Patchett, Edward W. Tristram, Eugene D. Thorsett, Matthew J. Wyvratt, Jr.
  • Substituted caprolactam derivatives as antihypertensives
    Patent number: 4409146
    Abstract: Substituted caprolactam derivatives are disclosed which are useful as converting enzyme inhibitors and as antihypertensives.
    Type: Grant
    Filed: July 2, 1982
    Date of Patent: October 11, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Eugene D. Thorsett, Elbert E. Harris
  • Substituted enantholactam derivatives as antihypertensives
    Patent number: 4396616
    Abstract: Substituted enantholactam dipeptides and derivatives thereof are disclosed which are useful as converting enzyme inhibitors and as antihypertensives.
    Type: Grant
    Filed: September 4, 1981
    Date of Patent: August 2, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Elbert E. Harris, David Taub, Eugene D. Thorsett
  • Substituted phosphonamides as antihypertensives
    Patent number: 4379146
    Abstract: There are disclosed substituted phosphonamides and related compounds which are useful as converting enzyme inhibitors and as antihypertensives.
    Type: Grant
    Filed: November 5, 1981
    Date of Patent: April 5, 1983
    Assignee: Merck & Co., Inc.
    Inventors: William J. Greenlee, Elbert E. Harris, Arthur A. Patchett, Eugene D. Thorsett
  • Aminoacid derivatives as antihypertensives
    Patent number: 4374829
    Abstract: The invention relates to new carboxyalkyl dipeptide derivatives and related compounds which are useful as antihypertensives.
    Type: Grant
    Filed: February 17, 1981
    Date of Patent: February 22, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Elbert E. Harris, Arthur A. Patchett, Edward W. Tristram, Matthew J. Wyvratt
  • Antimicrobial aminopyrimidinium salts
    Patent number: 4339453
    Abstract: 4-Amino- and 2,4-diaminopyrimidines with a quaternized ring nitrogen and an oxygen bearing substituent such as hydroxyalkyl, alkoxyalkyl, or alkanoyl on one of the exo- or endocyclic nitrogens and a C.sub.6-18 alkyl on another, are highly active antimicrobial agents with a relatively low acute mammalian toxicity.
    Type: Grant
    Filed: July 23, 1979
    Date of Patent: July 13, 1982
    Assignee: Merck & Co., Inc.
    Inventors: Nathaniel Grier, Elbert E. Harris, Henry Joshua, Arthur A. Patchett, Bruce E. Witzel, Richard A. Dybas
  • Aminoacid derivatives as antihypertensives
    Patent number: 4316896
    Abstract: The invention relates to new phosphoryl aminoacid derivatives and related compounds which are useful as antihypertensives.
    Type: Grant
    Filed: September 7, 1978
    Date of Patent: February 23, 1982
    Assignee: Merck & Co., Inc.
    Inventors: Eugene D. Thorsett, Arthur A. Patchett, Elbert E. Harris, Alan L. Maycock